A project from the American Society of Retina SpecialistsSign in to view content
Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration
- Video
- Published 2020
Related
Category: AMD-Non-Neovascular